New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Beleave Inc.
BLEVF
Shape
US Flag

PNK

Unprofitable

Unprofitable

566

Drug Manufacturers - Specialty & Generic

0.00USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-99%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

100%

Quote Panel

Shape
Updated October 24, 2024
1W % 1M % 3M % 1Y 0.00 %

Key Metrics

Shape
  • Market Cap

    566


  • Shares Outstanding

    566.37M


  • Share in Float

    496.32M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.000001


  • Average Volume


  • Beta

    25.247


  • Range

    1.0E-6-1.0E-5


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://beleave.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.00x

P/B Ratio

1.0

Debt/Equity

-1423.0%

Net Margin

$-0.0

EPS

How BLEVF compares to sector?

P/E Ratio

Relative Strength

Shape

BLEVF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.17

arrow
arrow

N/A

-0.00
vs -0.01

Q4.17

arrow
arrow

N/A

-0.01
vs -0.01

Q1.18

arrow
arrow

N/A

-0.02
vs -0.03

Q2.18

arrow
arrow

N/A

-0.05
vs -0.02

Q3.18

arrow
arrow

N/A

-0.01
vs -0.00

Q4.18

arrow
arrow

N/A

-0.00
vs -0.01

Q1.19

arrow
arrow

N/A

-0.02
vs -0.02

Q2.19

arrow
arrow

N/A

-0.00
vs -0.05

Q3.19

arrow
arrow

N/A

-0.01
vs -0.01

Q4.19

arrow
arrow

N/A

-0.00
vs -0.00

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.17

arrow
arrow

NA

NA  vs NA

Q4.17

arrow
arrow

NA

NA  vs NA

Q1.18

arrow
arrow

NA

NA  vs NA

Q2.18

arrow
arrow

NA

208.7K  vs NA

Q3.18

arrow
arrow

NA

315.6K  vs NA

Q4.18

arrow
arrow

NA

806.8K  vs NA

Q1.19

arrow
arrow

NA

1M  vs NA

Q2.19

arrow
arrow

+244%

718.7K  vs 208.7K

Q3.19

arrow
arrow

+139%

754.4K  vs 315.6K

Q4.19

arrow
arrow

-53%

381.9K  vs 806.8K

Return on EquityShape

status-upQoQ

Q1.18

arrow
arrow

-67%

-0.67
vs -0.17

Q2.18

arrow
arrow

-125%

-1.25
vs -0.67

Q3.18

arrow
arrow

-30%

-0.30
vs -1.25

Q4.18

arrow
arrow

-10%

-0.10
vs -0.30

Q1.19

arrow
arrow

-86%

-0.86
vs -0.10

Q2.19

arrow
arrow

-16%

-0.16
vs -0.86

Q3.19

arrow
arrow

-40%

-0.40
vs -0.16

Q4.19

arrow
arrow

-35%

-0.35
vs -0.40

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News